Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 120

1.

Plasma C-peptide concentration in women with Type 1 diabetes during early and late pregnancy.

Murphy HR, Elleri D, Allen JM, Simmons D, Nodale M, Hovorka R.

Diabet Med. 2012 Oct;29(10):e361-4. doi: 10.1111/j.1464-5491.2012.03747.x.

PMID:
22804483
2.

Pregnancy-induced rise in serum C-peptide concentrations in women with type 1 diabetes.

Nielsen LR, Rehfeld JF, Pedersen-Bjergaard U, Damm P, Mathiesen ER.

Diabetes Care. 2009 Jun;32(6):1052-7. doi: 10.2337/dc08-1832. Epub 2009 Feb 24.

3.

Pathophysiology of postprandial hyperglycaemia in women with type 1 diabetes during pregnancy.

Murphy HR, Elleri D, Allen JM, Harris J, Simmons D, Rayman G, Temple RC, Umpleby AM, Dunger DB, Haidar A, Nodale M, Wilinska ME, Hovorka R.

Diabetologia. 2012 Feb;55(2):282-93. doi: 10.1007/s00125-011-2363-6. Epub 2011 Nov 12.

PMID:
22080230
4.

Association of pre-pregnancy BMI and postpartum weight retention with postpartum HbA1c among women with Type 1 diabetes.

Huang T, Brown FM, Curran A, James-Todd T.

Diabet Med. 2015 Feb;32(2):181-8. doi: 10.1111/dme.12617. Epub 2014 Nov 19.

5.

Hypoglycaemia during pregnancy in women with Type 1 diabetes.

Ringholm L, Pedersen-Bjergaard U, Thorsteinsson B, Damm P, Mathiesen ER.

Diabet Med. 2012 May;29(5):558-66. doi: 10.1111/j.1464-5491.2012.03604.x. Review.

PMID:
22313112
6.

Safety, efficacy and glucose turnover of reduced prandial boluses during closed-loop therapy in adolescents with type 1 diabetes: a randomized clinical trial.

Elleri D, Biagioni M, Allen JM, Kumareswaran K, Leelarathna L, Caldwell K, Nodale M, Wilinska ME, Haidar A, Calhoun P, Kollman C, Jackson NC, Umpleby AM, Acerini CL, Dunger DB, Hovorka R.

Diabetes Obes Metab. 2015 Dec;17(12):1173-9. doi: 10.1111/dom.12549. Epub 2015 Oct 9.

7.

Closed-loop insulin delivery during pregnancy complicated by type 1 diabetes.

Murphy HR, Elleri D, Allen JM, Harris J, Simmons D, Rayman G, Temple R, Dunger DB, Haidar A, Nodale M, Wilinska ME, Hovorka R.

Diabetes Care. 2011 Feb;34(2):406-11. doi: 10.2337/dc10-1796. Epub 2011 Jan 7.

8.

Skipping meals or carbohydrate-free meals in order to determine Basal insulin requirements in subjects with type 1 diabetes mellitus?

Uthoff H, Lehmann R, Sprenger M, Wiesli P.

Exp Clin Endocrinol Diabetes. 2010 May;118(5):325-7. doi: 10.1055/s-0029-1241199. Epub 2010 Jan 12.

PMID:
20072961
9.

Use of glargine in pregnant women with type 1 diabetes mellitus: a case-control study.

Imbergamo MP, Amato MC, Sciortino G, Gambina M, Accidenti M, Criscimanna A, Giordano C, Galluzzo A.

Clin Ther. 2008 Aug;30(8):1476-84. doi: 10.1016/j.clinthera.2008.08.013.

PMID:
18803989
10.

Insulin during pregnancy, labour and delivery.

de Valk HW, Visser GH.

Best Pract Res Clin Obstet Gynaecol. 2011 Feb;25(1):65-76. doi: 10.1016/j.bpobgyn.2010.10.002. Epub 2010 Dec 24. Review.

PMID:
21186142
12.

Different intensities of glycaemic control for pregnant women with pre-existing diabetes.

Middleton P, Crowther CA, Simmonds L.

Cochrane Database Syst Rev. 2016 May 4;(5):CD008540. doi: 10.1002/14651858.CD008540.pub4. Review.

PMID:
27142841
13.

Safety of closed-loop therapy during reduction or omission of meal boluses in adolescents with type 1 diabetes: a randomized clinical trial.

Elleri D, Maltoni G, Allen JM, Nodale M, Kumareswaran K, Leelarathna L, Thabit H, Caldwell K, Wilinska ME, Calhoun P, Kollman C, Dunger DB, Hovorka R.

Diabetes Obes Metab. 2014 Nov;16(11):1174-8. doi: 10.1111/dom.12324. Epub 2014 Jul 6.

14.

Accuracy of continuous glucose monitoring during exercise in type 1 diabetes pregnancy.

Kumareswaran K, Elleri D, Allen JM, Caldwell K, Nodale M, Wilinska ME, Amiel SA, Hovorka R, Murphy HR.

Diabetes Technol Ther. 2013 Mar;15(3):223-9. doi: 10.1089/dia.2012.0292. Epub 2013 Feb 27.

15.

The impact of insulin administration during the mixed meal tolerance test.

Besser RE, Jones AG, McDonald TJ, Shields BM, Knight BA, Hattersley AT.

Diabet Med. 2012 Oct;29(10):1279-84. doi: 10.1111/j.1464-5491.2012.03649.x.

PMID:
22435709
17.

Effects of exogenous insulin on excursions and diurnal rhythm of plasma glucose in pregnant diabetic patients with and without residual beta-cell function.

Rigg L, Cousins L, Hollingsworth D, Brink G, Yen SS.

Am J Obstet Gynecol. 1980 Feb 15;136(4):537-44. No abstract available.

PMID:
6986776
18.

Fasting plasma glucose 6-12 weeks after starting insulin glargine predicts likelihood of treatment success: a pooled analysis.

Karl D, Zhou R, Vlajnic A, Riddle M.

Diabet Med. 2012 Jul;29(7):933-6. doi: 10.1111/j.1464-5491.2012.03640.x.

19.

Macrosomia despite good glycaemic control in Type I diabetic pregnancy; results of a nationwide study in The Netherlands.

Evers IM, de Valk HW, Mol BW, ter Braak EW, Visser GH.

Diabetologia. 2002 Nov;45(11):1484-9. Epub 2002 Sep 25.

PMID:
12436330
20.

Different intensities of glycaemic control for pregnant women with pre-existing diabetes.

Middleton P, Crowther CA, Simmonds L.

Cochrane Database Syst Rev. 2012 Aug 15;(8):CD008540. doi: 10.1002/14651858.CD008540.pub3. Review. Update in: Cochrane Database Syst Rev. 2016;(5):CD008540.

Supplemental Content

Support Center